Search results for: "Novo Nordisk"

(283 records)

Ingredients
Innovative new process used to produce a diabetes and weight loss drug

Innovative new process used to produce a diabetes and weight loss drug

Camilla Koller, Marketing Communications Associate, tells Dr Kevin Robinson how Bachem has used its extensive experience and expertise in peptide synthesis to develop a fully...
Drug Delivery
Optibrium appoints new strategic leader

Optibrium appoints new strategic leader

Tim Hohm has been named new Director of Commercial Strategy and Business Development
Personal Protection
Coronavirus: Emergency planning for the drug supply chain

Coronavirus: Emergency planning for the drug supply chain

The FDA has outlined its expectations and actions regarding supply chain and inspections in China
Design & Build
Novo Nordisk plans $117m API manufacturing expansion

Novo Nordisk plans $117m API manufacturing expansion

Danish company’s Kalundborg headquarters that manufactures insulin API will be expanded by 2022
Manufacturing
Novo Nordisk donates $40m wastewater pre-treatment facility

Novo Nordisk donates $40m wastewater pre-treatment facility

The pre-treatment plant will serve Novo Nordisk’s new $2bn API manufacturing facility, but will be able to treat almost 450,000 gallons a day to serve other pharma facilities...
Research & Development
Novo Nordisk funds $27m global biomanufacturing programme

Novo Nordisk funds $27m global biomanufacturing programme

The five-year research and training project will be run as a collaborative effort between North Carolina State University and the Technical University of Denmark
Finance
Purdue Pharma sells North Carolina site to Novo Nordisk

Purdue Pharma sells North Carolina site to Novo Nordisk

The solid dose manufacturing site will be refurbished to manufacture tablets for oral semaglutide (diabetes treatment) and future oral medicines
Manufacturing
Novo Nordisk expands Danish production facilities

Novo Nordisk expands Danish production facilities

Almost US$100 million will be spent in Danish production sites to upgrade facilities to manufacture next generation diabetes treatment products
Research & Development
CPhI Japan: Internationalisation reaches new heights

CPhI Japan: Internationalisation reaches new heights

Innovation in the country, driven by structural and and regulatory changes, has promoted both inbound and outbound collaboration
Finance
Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agreement with DKSH

Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agreement with DKSH

The Danish pharma company and the Swiss market expansion expert have partnered to provide high-quality cGMP quaternary ammonium compounds in eleven markets across the region
Media
Bayer receives European approval for haemophilia drug Jivi ... but has stiff competition ahead

Bayer receives European approval for haemophilia drug Jivi ... but has stiff competition ahead

Germany-based pharma major Bayer has recently received the European Commission approval for its haemophilia A long-acting injectable medicine Jivi
Corporates Outlook 2019/Pharmaceuticals

Corporates Outlook 2019/Pharmaceuticals

Patent expiry is the pharmaceutical sector’s perennial problem. Sales of blockbuster drugs can fall off a cliff in the face of generic competition, but the next patent cliff...
Media
Significant advances in diabetes medicine have been made, but many unmet needs remain

Significant advances in diabetes medicine have been made, but many unmet needs remain

Advances in diabetes medicine, such as antidiabetic oral medications, incretin therapies and novel insulin formulations have been made during the past century, but many unmet...
Manufacturing
WuXi Biologics CEO joins ISPE Board

WuXi Biologics CEO joins ISPE Board

Dr Chris Chen is the first board member to join ISPE board of directors from Asia
Recruitment
Ashfield appoints new Managing Director

Ashfield appoints new Managing Director

Media
Bristol diabetes spin-out company acquired by Novo Nordisk

Bristol diabetes spin-out company acquired by Novo Nordisk

The global healthcare company has acquired all of the shares of the Bristol supramolecular chemistry company, of which total payments under the agreement could ultimately...

Trending Articles

  1. Nicox’s NCX 470 new drug application submitted in the United States by Kowa The submission is based on positive results from two Phase III clinical trials (Mont Blanc and Denali)
  2. Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology The agreement will install KinetiSol Formulator equipment across Patheon's Bend and Cincinnati OSD sites, offering pharma customers an integrated development-to-commercial pathway for poorly soluble drug candidates
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Annex 1 at the transfer point: how to meet the evolving evidence challenge As Annex 1 raises expectations for contamination control, transfer-point evidence must become more dynamic, connected and defensible throughout the entire product lifecycle
  4. Sanofi offers EU commitments for flu vaccine disparagement claims Sanofi has proposed remedies to EU antitrust regulators after allegations it disparaged rival CSL Seqirus's Fluad vaccine in Germany and France since 2024
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Back to basics: a simple guide to checkweighing in pharmaceutical production Mettler-Toledo’s Miriam Krechlok tells Dr Kevin Robinson how checkweighing helps pharmaceutical manufacturers to verify product completeness, control fill levels and maintain compliance, safety and efficiency

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Digital The AI-driven biotech and China Medical System have struck a second collaboration in three months, targeting a mass-market CNS indication via a novel mechanism identified by...
Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Read more
Research & Development The global study builds on US POINTER trial findings, testing whether adding a metabolism-targeting drug to structured lifestyle programmes can further reduce cognitive decline...
Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Read more
Manufacturing Piramal Pharma Limited (PPL) (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a...
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Read more
Manufacturing The FDA's pre-licence inspection approval of WuXi Biologics' MFG8 facility will strengthen the CRDMO's commercial manufacturing network, supporting the global supply of a...
WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

Read more
Manufacturing Boehringer Ingelheim has selected the osapiens HUB for Mobile Maintenance for its global, regulated manufacturing operations
Boehringer Ingelheim standardises plant maintenance globally with osapiens

Boehringer Ingelheim standardises plant maintenance globally with osapiens

Read more
Manufacturing With throughput up to 100 kg/h, the new twin-screw extruder brings lab-grade process understanding into pilot-scale production, enabling users to validate process parameters...
Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

Read more
Dosage Forms While injection pens and weight-loss pills are gaining ground across the Western world, the debate focuses one-sidedly on the kilos and not on the body’s health and the...
Obesity medication: fast results … but at the expense of long-term health

Obesity medication: fast results … but at the expense of long-term health

Read more
Pharmaceutical The agreement will expand Teva’s biosimilars pipeline, with the company securing exclusive commercialisation rights for Polpharma Biologics’ proposed ocrelizumab biosimilar...
Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

Read more